These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium. Kilts CD J Clin Psychiatry; 2000; 61 Suppl 9():41-6. PubMed ID: 10826660 [TBL] [Abstract][Full Text] [Related]
3. The clinical significance of lithium-nonsteroidal anti-inflammatory drug interactions. Ragheb M J Clin Psychopharmacol; 1990 Oct; 10(5):350-4. PubMed ID: 2258452 [TBL] [Abstract][Full Text] [Related]
4. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice. Coryell W Bipolar Disord; 2009 Jun; 11 Suppl 2():77-83. PubMed ID: 19538687 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: an argument for the use of lithium. Muzina DJ Bipolar Disord; 2009 Jun; 11 Suppl 2():84-91. PubMed ID: 19538688 [TBL] [Abstract][Full Text] [Related]
6. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study. Biel MG; Peselow E; Mulcare L; Case BG; Fieve R Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913 [TBL] [Abstract][Full Text] [Related]
7. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. Manji HK; Moore GJ; Chen G J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666 [TBL] [Abstract][Full Text] [Related]
8. [Predictors of prophylactic response to lithium]. Rohayem J; Baylé JF; Richa S Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242 [TBL] [Abstract][Full Text] [Related]
9. Cytokine production in bipolar affective disorder patients under lithium treatment. Boufidou F; Nikolaou C; Alevizos B; Liappas IA; Christodoulou GN J Affect Disord; 2004 Oct; 82(2):309-13. PubMed ID: 15488263 [TBL] [Abstract][Full Text] [Related]
10. [Calcium antagonists and lithium in preventive treatment of manic-depressive disorder]. Sarfati Y; Spadone C; Vanelle JM; Lôo H Encephale; 1996; 22(2):149-53. PubMed ID: 8706625 [TBL] [Abstract][Full Text] [Related]
15. Lithium: a review of its pharmacokinetics, health effects, and toxicology. Marcus WL J Environ Pathol Toxicol Oncol; 1994; 13(2):73-9. PubMed ID: 7884646 [TBL] [Abstract][Full Text] [Related]
16. The role of lithium in modulation of brain genes: relevance for aetiology and treatment of bipolar disorder. Fatemi SH; Reutiman TJ; Folsom TD Biochem Soc Trans; 2009 Oct; 37(Pt 5):1090-5. PubMed ID: 19754458 [TBL] [Abstract][Full Text] [Related]
17. Neurobiology of lithium: an update. Lenox RH; McNamara RK; Papke RL; Manji HK J Clin Psychiatry; 1998; 59 Suppl 6():37-47. PubMed ID: 9674936 [TBL] [Abstract][Full Text] [Related]
18. [Long-term lithium prophylaxis in the bipolar affective disorder]. Suwalska A; Chłopocka-Woźniak M; Rybakowski J Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423 [TBL] [Abstract][Full Text] [Related]
19. Report on efficacy of treatments for bipolar disorder. Gelenberg AJ; Hopkins HS Psychopharmacol Bull; 1993; 29(4):447-56. PubMed ID: 8084977 [TBL] [Abstract][Full Text] [Related]
20. [On the relevance of protein kinase C to lithium therapy in bipolar disorder]. Sela B Harefuah; 2004 Jun; 143(6):414-6, 462. PubMed ID: 15524097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]